The authors suggest that biglycan acts as a repressor of the expression of amelogenin in the two unique groups of cells involved in amelogenin synthesis, namely, the secretory ameloblasts and odontoblasts.
No takes yet. Share an insight, caveat, or question.
Goldberg et al. (2002) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: